CORAL Renal Trial To Show Risks, Benefits Of Stenting Over Drugs
This article was originally published in The Gray Sheet
Executive Summary
The Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) trial likely will provide the first definitive evidence on the benefits of renal stenting, according to Julio Palmaz, MD, University of Texas